Equities

Optomed Oyj

Optomed Oyj

Actions
  • Price (EUR)5.08
  • Today's Change0.07 / 1.40%
  • Shares traded723.00
  • 1 Year change+73.08%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 07:01 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments7.128.526.80
Total Receivables, Net2.683.783.82
Total Inventory2.823.002.94
Prepaid expenses0.510.790.81
Other current assets, total------
Total current assets131614
Property, plant & equipment, net2.182.301.64
Goodwill, net4.264.264.26
Intangibles, net9.498.648.72
Long term investments------
Note receivable - long term------
Other long term assets----0.00
Total assets293129
LIABILITIES
Accounts payable0.780.870.94
Accrued expenses1.961.941.58
Notes payable/short-term debt0.190.190.19
Current portion long-term debt/capital leases1.311.211.47
Other current liabilities, total0.811.020.73
Total current liabilities5.055.234.91
Total long term debt3.365.346.57
Total debt4.866.748.23
Deferred income tax0.310.390.46
Minority interest------
Other liabilities, total0.000--
Total liabilities8.721112
SHAREHOLDERS EQUITY
Common stock0.080.080.08
Additional paid-in capital0.500.500.50
Retained earnings (accumulated deficit)192017
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.330.05(0.09)
Total equity202017
Total liabilities & shareholders' equity293129
Total common shares outstanding181614
Treasury shares - common primary issue0.350.370.42
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.